Global Angina Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Angina Market Research Report 2024
Angina is a type of chest pain caused by reduced blood flow to the heart. Angina (an-JIE-nuh or AN-juh-nuh) is a symptom of coronary artery disease. Angina, which may also be called angina pectoris, is often described as squeezing, pressure, heaviness, tightness or pain in your chest
According to MRAResearch’s new survey, global Angina market is projected to reach US$ 14180 million in 2033, increasing from US$ 10400 million in 2022, with the CAGR of 4.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Angina market research.
Key companies engaged in the Angina industry include Amgen, Taxus Cardium Pharmaceuticals, LegoChem Biosciences, Lee’s Pharmaceutical, Milestone Pharmaceuticals, Juventas Therapeutics, ViroMed and Kuhnil Pharmaceutical, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Angina were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Angina market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Angina market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Amgen
Taxus Cardium Pharmaceuticals
LegoChem Biosciences
Lee’s Pharmaceutical
Milestone Pharmaceuticals
Juventas Therapeutics
ViroMed
Kuhnil Pharmaceutical
Segment by Type
Beta Blockers
Calcium Antagonists
Anticoagulants
Antiplatelet
Nitrates
ACE Inhibitors
Ranolazine
Clinics
Hospitals
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Angina report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Angina market is projected to reach US$ 14180 million in 2033, increasing from US$ 10400 million in 2022, with the CAGR of 4.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Angina market research.
Key companies engaged in the Angina industry include Amgen, Taxus Cardium Pharmaceuticals, LegoChem Biosciences, Lee’s Pharmaceutical, Milestone Pharmaceuticals, Juventas Therapeutics, ViroMed and Kuhnil Pharmaceutical, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Angina were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Angina market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Angina market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Amgen
Taxus Cardium Pharmaceuticals
LegoChem Biosciences
Lee’s Pharmaceutical
Milestone Pharmaceuticals
Juventas Therapeutics
ViroMed
Kuhnil Pharmaceutical
Segment by Type
Beta Blockers
Calcium Antagonists
Anticoagulants
Antiplatelet
Nitrates
ACE Inhibitors
Ranolazine
Segment by Application
Clinics
Hospitals
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Angina report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source